Palforzia, the first peanut allergy treatment, finally gets FDA approval

A few months after the FDA announced a major step toward the eventual approval of a peanut allergy treatment, the big day has finally arrived. Aimmune Therapeutics has announced that its Palforzia peanut allergy treatment has received FDA approval for patients ages four through 17. Before you get too excited, though, take note: this treatment is meant to help protect …